Enbrel and Humira Now Have Automated Delivery System

The Food and Drug Administration (FDA) has approved automated delivery systems for both Humira^® (adalimumab) and Enbrel^® (etanercept). The Humira Pen and Enbrel SureClick^TM will be available for patient use in the first week of August 2006. In both systems, the medication is in a prefilled pen-like device and the needle is not visible to the patient. There is no change in dosing and there is no additional cost to the patients.

The current delivery method of prefilled syringes will remain available. Clinicians will have to specifically prescribe the Humira Pen or Enbrel SureClick^TM.

All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.